Samsung Invests in Drugs After Outselling Apple’s IPhone

14th May 2014

Samsung (005930) Group transformed its electronics unit into the world’s largest smartphone maker by outselling Apple Inc. (AAPL) Now it’s setting sights on the drug industry.

South Korea’s biggest company is investing at least $2 billion in biopharmaceuticals, including the growing segment of biosimilars, which are cheaper versions of brand-name biotechnology drugs that have lost patent protection.

 

Read full article at source www.bloomberg.com


Leave a Reply

Your email address will not be published.

73 + = 77

« back to posts